MetaVia Inc.
MTVA
Kedudukan dalam Saham
#32904
Headquartered in Cambridge, Massachusetts, MetaVia Inc. operates as a... Headquartered in Cambridge, Massachusetts, MetaVia Inc. operates as a clinical-stage biotechnology company with a core focus on discovering and commercializing novel pharmaceutical solutions for cardiometabolic disorders. Its leading investigational drug, DA-1241, a unique G-Protein-Coupled Receptor 119 agonist, is currently undergoing Phase 2a clinical trials for metabolic dysfunction-associated steatohepatitis (MASH). This follows the successful completion of Phase 1 trials for type 2 diabetes mellitus (T2DM), and the compound holds promise for use as both a standalone therapy and in combination treatments. Another significant asset, DA-1726, an innovative oxyntomodulin analogue that functions as a dual agonist for GLP-1 and glucagon receptors, is presently in preclinical development specifically for treating obesity. MetaVia's broader therapeutic pipeline also includes ANA001, a distinct oral niclosamide formulation intended for moderate COVID-19 patients; NB-01, designed to address painful diabetic neuropathy; NB-02, targeting cognitive impairment; and Gemcabene, for the management of dyslipidemia. The company engages in strategic partnerships, notably a licensing agreement with Pfizer Inc. for the research, development, manufacturing, and commercialization of Gemcabene. Additionally, a joint research collaboration with Dong-A ST and ImmunoForge supports the advancement of DA-1726. The entity adopted its current name, MetaVia Inc., in November 2024, transitioning from its former identity as NeuroBo Pharmaceuticals, Inc.
Harga Saham
$1.28
Disegerakkan terakhir: 2026-10-20
Modal Pasaran
$8.43M
Perubahan (1 hari)
4.07%
Perubahan (1 tahun)
-21.47%
Negara
US
Perdagangan MetaVia Inc. (MTVA)
Kategori
Healthcare
Sejarah pecahan saham untuk MetaVia Inc. (MTVA)
Saham MetaVia Inc. (simbol: MTVA) telah mengalami sejumlah 3 pecahan saham.
Pecahan saham terkini berlaku pada Dec 21, 2023.
Satu saham MTVA yang dibeli sebelum Dec 31, 2019 kini bersamaan dengan 0.00016666666666667 saham MTVA.
Pecahan saham terkini berlaku pada Dec 21, 2023.
Satu saham MTVA yang dibeli sebelum Dec 31, 2019 kini bersamaan dengan 0.00016666666666667 saham MTVA.
Senarai pecahan saham
| Tahun | Pecahan | Gandaan | Gandaan Kumulatif |
|---|---|---|---|
| 2023-12-21 | 1:8 | x0.125 | x0.00016666666666667 |
| 2022-09-13 | 1:30 | x0.033333333333333 | x0.0013333333333333 |
| 2019-12-31 | 1:25 | x0.04 | x0.04 |
Pecahan saham untuk syarikat pesaing atau serupa
| Syarikat | Bilangan pecahan saham | Gandaan Kumulatif | Negara |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
CH
|
|
| 0 | - |
NL
|
